1202 SEQUENCE ANALYSIS OF HCV VARIANTS FROM A PHASE IIA TRIAL OF MIRAVIRSEN (MIR), AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT NAIVE PATIENTS WITH CHRONIC HCV INFECTION
Authors:
- A.K. PatickAPA.K. Patick
- A. ChenACA. Chen
- L.J. van DoornLDL.J. van Doorn
- E. van der VeerEVE. van der Veer
- K. ZehKZK. Zeh
- A.K. RaneyARA.K. Raney
- M.R. HodgesMHM.R. Hodges
- 1 April 2012
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 56, S476